The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
 
Pamela L. Kunz
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Guardant Health; Ipsen; Novartis
Research Funding - Advanced Accelerator Applications; Genentech/Roche; Lexicon; Merck; Merrimack; Novartis; Pharm-Olam
 
Paul J. Catalano
Research Funding - Lilly
 
Halla Sayed Nimeiri
No Relationships to Disclose
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Consulting or Advisory Role - Genentech
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Medivation (Inst); Newlink Genetics (Inst); Novartis (Inst); Pharmaceutical Research Associates (Inst); Polaris (Inst); PRA International (Inst); Tercica (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Teri A. Longacre
No Relationships to Disclose
 
Iris Schrijver
No Relationships to Disclose
 
Diane Lauren Reidy
No Relationships to Disclose
 
Jonathan R. Strosberg
Honoraria - Genentech
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
 
Peter J. O'Dwyer
Stock and Other Ownership Interests - TetraLogic Pharmaceuticals
Consulting or Advisory Role - Five Prime Therapeutics; Genentech
Research Funding - BMS, Pfizer, Novartis, Genentech, Mirati, Celgene, GSK, BBI
Expert Testimony - Lilly
 
Al Bowen Benson
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone; Merck Serono; Merck/Schering Plough; Sanofi; Spectrum Pharmaceuticals
Research Funding - advanced accelerator applications; Amgen; Astellas Pharma; Bayer/Onyx; Genentech (I); Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Bayer; Genentech/Roche; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals